Key facts
- Notable investors include Korea Investment Partners, DAYLI Partners, Mint Venture Partners.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Beamworks
- ·The full record, as it builds
Funding rounds
No funding rounds for Beamworks are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Beamworks
Developer of real-time AI ultrasound diagnostic tools designed to enhance breast cancer detection accuracy. The company's platform utilizes an on-device AI system that processes ultrasound data in real-time without the need for server connectivity, achieving detection sensitivity and differential diagnosis performance, enabling healthcare providers to offer precise and timely diagnostics and improve patient outcomes, and reduce unnecessary procedures.
- Sector
- Healthcare
- HQ
- Daegu, South Korea
- Founded
- 2021
- Website
- beamworks.co.kr/
- Ownership
- Privately Held (backing)
Beamworks doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Beamworks shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Beamworks in its N-PORT filings yet. We sweep new filings monthly.